Equity · Healthcare
Kodiak Sciences Inc. (KOD) perpetual futures
KOD perpetual futures on 2 crypto exchanges – live perp price vs the stock, funding rate, open interest and where to trade KODUSDT.
Kodiak Sciences is a clinical-stage biopharmaceutical company developing treatments for retinal diseases, led by its anti-VEGF antibody biopolymer candidate KSI-301 in Phase IIb/III trials.
Price chart
Interactive TradingView chart
TradingView symbol NASDAQ:KOD
Loads TradingView's third-party widget (about 1 MB) on demand.
Trading data
Perpetual market activity
2/3 live markets
Trading data
Perpetual market activity
Spot performance
Venue matrix
3 markets
Some venue links are sponsored. We may receive a commission, and eligible users may occasionally receive trading-fee discounts, at no additional cost to you.
Bitget
BingX
MEXCTradability
Execution quality
Entry cost and depth per venue at $1k–$100k
Tradability
Execution quality
Entry cost and depth per venue at $1k–$100kThin liquidity · 2 of 2 venues absorb $10k · Typical cost: +70.8 bps – +114.0 bps
Cheapest execution: Bitget · +49.3 bps
Taker execution estimate incl. approx. fees - maker fills are not guaranteed.
Best venues for this underlying
Best liquidity
KODTightest spread
KODHighest volume
KODFunding history
Stored venue snapshots by market
Funding history
Stored venue snapshots by marketNext catalyst
Catalysts
Next catalyst
Catalysts
No unusual perp activity right now.
Research data
Analysts, filings and peer context
Research data
Analysts, filings and peer context
Estimates
6Company events
6Peer comparison
Similar listed perpsAnalysts
Price targets in USD| Consensus rating | Buy |
|---|---|
| Average 12-month price target | $115.25 |
| 12-month target range (low – high) | $103 – $126 |
| Ratings in the provider's consensus | 19 |
Price targets as of 2026-11-13
Analyst rating history
Ratings| Month | Strong buy | Buy | Hold | Sell | Strong sell |
|---|---|---|---|---|---|
| Nov 2026 | 1 | 5 | 1 | 0 | 0 |
| Oct 2026 | 1 | 5 | 1 | 0 | 0 |
| Sep 2026 | 1 | 5 | 1 | 0 | 0 |
| Aug 2026 | 1 | 5 | 0 | 0 | 0 |
| Jul 2026 | 1 | 6 | 0 | 0 | 0 |
| Jun 2026 | 1 | 6 | 0 | 0 | 0 |
| May 2026 | 1 | 6 | 1 | 0 | 0 |
| Apr 2026 | 1 | 5 | 1 | 0 | 0 |
| Mar 2026 | 1 | 5 | 1 | 0 | 0 |
| Feb 2026 | 1 | 5 | 1 | 1 | 0 |
| Jan 2026 | 1 | 5 | 2 | 1 | 0 |
| Dec 2025 | 1 | 4 | 2 | 1 | 0 |
Ownership
Institutional · 2025-Q4Reference market activity
KOD-PERPPrice performance
11Insider activity
FY2026 Q4Insider transactions
25Baker Bros. Advisors LP, a Kodiak Sciences director and 10% owner, made 4 open-market purchases of common stock on Nov 4-5, 2026, totaling 247,090 shares at $98.51 each.
Director Yang Taiyin exercised 20,000 stock options at $2.35 for 20,000 shares of Kodiak Sciences common stock, a single exercise covering the same shares; 20,000 common shares were held after.
Kodiak Sciences CFO John A. Borgeson exercised 30,000 stock options into 30,000 common shares and sold all 30,000 shares in 8 open-market trades at $87.67–$94.91; 211,930 shares remain.
Baker Bros. Advisors LP bought 656,157 Kodiak Sciences common shares in 9 open-market transactions on Sept 28-29, 2026, at $84.24-$89.86 per share.
Filings
41 · Latest SEC filingsBaker Bros. Advisors LP, a Kodiak Sciences director and 10% owner, made 4 open-market purchases of common stock on Nov 4-5, 2026, totaling 247,090 shares at $98.51 each.
Director Yang Taiyin exercised 20,000 stock options at $2.35 for 20,000 shares of Kodiak Sciences common stock, a single exercise covering the same shares; 20,000 common shares were held after.
Kodiak Sciences CFO John A. Borgeson exercised 30,000 stock options into 30,000 common shares and sold all 30,000 shares in 8 open-market trades at $87.67–$94.91; 211,930 shares remain.
Baker Bros. Advisors LP bought 656,157 Kodiak Sciences common shares in 9 open-market transactions on Sept 28-29, 2026, at $84.24-$89.86 per share.
Baker Bros. Advisors LP, a Kodiak Sciences director and 10% owner, bought 418,323 common shares in 30 open-market purchases on 2026-09-28 at $79.4045–$85.9656, ending with 19,515,907 shares held.
Baker Bros. Advisors LP, a Kodiak Sciences director and 10% owner, bought 807,840 common shares in 30 open-market purchases on Sept 28, 2026, at $61.21–$78.57, ending with 19,121,134 shares owned.
Kodiak Sciences CEO Victor Perlroth exercised 1,280,524 options (M-Exempt) at $2.49–$5.38, converting them into the same number of common shares; he holds 2,995,538 shares after.
KOD director, 10% owner and CEO Victor Perlroth received a grant of 100,000 stock options (right to buy) at $42.42 per share on July 15, 2026, leaving him with 100,000 owned. This was an award, not an open-market purchase.
KOD CFO John A. Borgeson was granted stock options (A-Award) for 66,500 shares at $42.42 per share on 2026-07-15, bringing his holdings to 66,500.
Director Levy Richard S received an award of 17,731 stock options (right to buy) at $38.96 per share on 2026-06-30. After the grant, he owned 17,731 such options.
Director Robert Profusek received an award of 17,731 stock options (right to buy) at $38.96 per share on 2026-06-30, leaving him with 17,731 owned after. Filed as Form 4 on 2026-07-02.
KOD director Dahiyat Bassil I received 17,731 stock options at $38.96 per share via an A-Award grant on June 30, 2026, leaving 17,731 owned after.
KOD director and 10% owner Baker Bros. Advisors LP received an award of 17,731 non-qualified stock options (right to buy) at $38.96 per share on 2026-06-30, leaving 17,731 options owned after.
Director Bancroft Charles A was granted stock options on 17,731 shares at $38.96 per share on 2026-06-30, per a Form 4 filed 2026-07-02.
Director Yang Taiyin received an award of 17,731 stock options (right to buy) at $38.96 per share on 2026-06-30, holding 17,731 after.
Kodiak Sciences CFO John A. Borgeson exercised options on 30,000 common shares at $1.04, converting the same 30,000 stock options, then sold 30,000 common shares at $34.01-$34.67.
Kodiak Sciences CFO John A. Borgeson exercised options on 28,614 shares at $1.04, converting options into common stock. He held 211,930 shares afterward.
Kodiak Sciences CFO John A. Borgeson exercised 30,000 options at $1.04 and sold 30,000 common shares at $39.14-$41.77 on 2026-04-02, leaving 183,316 shares directly held.
Kodiak Sciences director/CEO Victor Perlroth exercised 300,000 stock options at $1.04 each, converting them into 300,000 common shares; he held 2,395,538 shares after.
Transcripts
PendingCompany news
Reuters, WSJ, Bloomberg and FT first, as far as our news provider delivers them; other publishers behind the second filter. Headlines link to the publisher.No articles from Reuters, WSJ, Bloomberg or FT for this company in our feed.
Company data
Company intelligence
Updated: Nov 12, 2026, 10:05 PM UTC
Company data
Company intelligence
Company profile
- Sector
- Healthcare
- Industry
- Biotechnology
- Chief executive
- Victor Perlroth
- Employees
- 141
- IPO date
- Oct 4, 2018
- Country
- US
- Exchange
- NASDAQ Global Market
Rating factors
- Return on equityi
- 1/5
- Return on assetsi
- 1/5
- Debt to equityi
- 1/5
- Price to earningsi
- 1/5
- Price to booki
- 1/5
Company press releases
Congressional disclosures
Market cap history
Largest fund holders
| Fund | Weight | Shares held |
|---|---|---|
| XBI | 1.25% | 1.4M |
| VTI | 0.01% | 1.3M |
| IWM | 0.13% | 1M |
| NJM | 0.04% | 896.5K |
| IBB | 0.39% | 452.1K |
| VXF | 0.05% | 446.3K |
| IWO | 0.26% | 369.6K |
| NAJ | 0.08% | 329.6K |
| VTWO | 0.12% | 228.5K |
| SCHA | 0.09% | 210.2K |
| VEXPX | 0.09% | 204K |
| FSMAX | 0.05% | 172.5K |
Analyst track record
How the analysts covering KOD have done: ratings, price-target accuracy and the measured reaction after their calls.
| 12 months | 3 years | |
|---|---|---|
| Ratings | 45 | 81 |
| Analysts | 10 | 13 |
| Buy / hold / sell | 40 / 5 / 0 | 49 / 19 / 13 |
| Upgrades / downgrades / initiations | 2 / 0 / 3 | 7 / 0 / 7 |
| Price targets hit / missed | 34 / 5 (87%) | 68 / 5 (93%) |
| Avg. return after a rating (TipRanks) | +112.7% | +1,090.1% |
| Best / worst call | +645.5% / -28.0% | > +1,000% / -28.0% |
After buy calls on this stock: median 21-day move +4.0% vs S&P 500 +5.8% (n = 49)
Most accurate on this stock
Share of an analyst's price targets on this stock that the price reached within 12 months (our measurement over the last 3 years, at least 8 targets). It describes past calls, not the odds of the current one.
- Gena WangBarclays73% hit rate on this stock · 11 targets measuredHoldtarget $17.00Nov 17, 2025
Latest ratings
| Date | Analyst | Call | Target | |
|---|---|---|---|---|
| Nov 13, 2026 | Michael YeeUBSNov 13, 2026 | BuyReiterated | $150↗ | article ↗ |
| Oct 12, 2026 | Matthew CaufieldH.C. WainwrightOct 12, 2026 | BuyReiterated | $126↗ | article ↗ |
| Oct 5, 2026 | Maury RaycroftJefferiesOct 5, 2026 | BuyMaintained | $112↗ | article ↗ |
| Sep 29, 2026 | Andrea NewkirkGoldman SachsSep 29, 2026 | HoldMaintained | $103↗ | article ↗ |
| Sep 28, 2026 | Anupam RamaJ.P. MorganSep 28, 2026 | BuyMaintained | –↗ | article ↗ |
Share of analysts per call each month (latest call per analyst within 180 days). Targets and closes in USD.
TipRanks data · computed Nov 13, 2026 · 45 ratings
Frequently asked questions
Where can I trade KOD perpetual futures?
Kodiak Sciences Inc. (KOD) perpetual futures trade on 2 crypto venues, including Bitget, BingX. PerpEquities compares them by live price, funding rate, open interest and liquidity.
Can I trade KOD around the clock?
Yes. Unlike the underlying stock, KOD perpetuals trade 24/7 — including weekends and outside regular market hours.
What is the funding rate on KOD perpetuals?
Right now the KOD perp funding rate is -2.7% annualized (venue median), ranging from -5.5% to 0.0% across 2 venues. A positive rate means longs pay shorts. PerpEquities shows the live rate and its history for every venue.
How does the KOD perp price compare to the Kodiak Sciences Inc. stock?
The venue-median KOD perp mark is $107.8 versus a reference stock price of $107.8, a basis of 0.0%. Perps follow the stock through an index price; the gap widens when funding or liquidity diverge between venues.
What is a KOD perpetual future?
A KOD perpetual is a derivative that tracks the price of Kodiak Sciences Inc. with no expiry date. It lets you take long or short exposure to Kodiak Sciences Inc. on crypto venues, around the clock.
What is KODUSDT perpetual?
KODUSDT is the symbol most crypto exchanges use for the Kodiak Sciences Inc. perpetual settled in USDT (Tether). It tracks the KOD share price through an index, trades 24/7 with leverage and never expires.
Embed this asset
<a href="https://perpequities.com/stocks/kod-perp"><img src="https://perpequities.com/badge/kod-perp.svg" width="240" height="64" alt="KOD perpetuals · perpequities.com" loading="lazy"></a>